Since there is no abstract available, we provide the first paragraph
In a recent issue of the Journal Annals of Surgical Oncology Morrogh and colleagues, [1] rationally highlight the impact of a recent landmark study [2] on society and women who will receive a new diagnosis of breast cancer. Reports have emphasized the increased risk of local recurrence following breast-conserving therapy (BCT) particularly among young patients and those who underwent surgery with inadequate margin [3, 4] before the publication of the Early Breast Cancer Trialists Collaborative Group (EBCTCG) early-stage breast cancer meta-analysis [2]. However, this meta-analysis reveals also an increased risk of death among patients in whom local recurrence occurs
